IFNG and neoplasm: Various immunocytokines have been combined with additional unconjugated cytokines such as IL-7, IL-2, Fms-like tyrosine kinase-3-ligand (Flt3-L), and IFN-γ to show enhanced tumor control and the activation of the immune response [85,178,179,180].